The influence of diabetes on the relationship between N-terminal pro-B-type natriuretic peptide and body mass index

Journal of International Medical Research

Volumn 38, Issue 5, 2010, Pages 1737-1748

  Kim, B H ^a,c   Kim, I J ^a   Cho, K I ^b   Kim, S M ^b   Lee, H G ^b   Kim, T I ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Department of Internal Medicine   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

B type Natriuretic peptide; Body mass index; Congestive heart failure; Diabetes; Obesity

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; UREA;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; BLOOD VESSEL WALL; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; CREATININE BLOOD LEVEL; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; FEMALE; GEOMETRY; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

EID: 78449291257     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800519     Document Type: Article

References (31)

1. Maisel AS, Krishnaswamy P, Nowak RM, et al: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
2. Maeda K, Tsutamoto T, Wada A, et al: Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-832.
3. Friedl W, Mair J, Thomas S, et al: Natriuretic peptides and cyclic guanosine 3′,5′- monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart 1996; 76: 129-136.
4. Maisel AS, Clopton P, Krishnaswamy P, et al: Impact of age, race, and sex on the ability of B- type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 2004; 147: 1078-1084.
5. Wang TJ, Larson MG, Levy D, et al: Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594-600.
6. Krauss RM, Winston M, Fletcher BJ, et al: Obesity: impact on cardiovascular disease. Circulation 1998; 98: 1472-1476.
7. Alpert MA, Lambert CR, Terry BE, et al: Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity. Am Heart J 1995; 130: 1068-1073.
8. Rivera M, Cortés R, Salvador A, et al: Obese subjects with heart failure have lower N- terminal pro-brain natriuretic peptide plasma levels irrespective of etiology. Eur J Heart Fail 2005; 7: 1168-1170.
9. Taylor JA, Christenson RH, Rao K, et al: B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J 2006; 152: 1071-1076.
10. Görmüş U, Ozmen D, Ozmen B, et al: Serum N-terminal-pro-brain natriuretic peptide (NT-pro- BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction. Diabetes Res Clin Pract 2010; 87: 51-56.
11. AHA Science Advisory: Assessment of functional capacity in clinical and research applications. Circulation 2000; 102: 1591-1597.
12. American Diabetes Association: Standards of medical care in diabetes - 2009. Diabetes Care 2009; 32(suppl 1): S13-S61.
13. Koh JH, Koh SB, Lee MY, et al: Optimal waist circumference cutoff values for metabolic syndrome diagnostic criteria in a Korean rural population. J Korean Med Sci 2010; 25: 734-737.
14. Cheitlin MD, Armstrong WF, Aurigemma GP, et al: ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003; 108: 1146-1162.
15. Devereux RB, Alonso DR, Lutas EM: Echocardiographic assessment of left ventricular hypertrophy: comparison with necropsy findings. Am J Cardiol 1986; 57: 450-458.
16. Ganau A, Devereux RB, Roman MJ, et al: Patterns of left ventricular hypertrophy and geometric remodelling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558.
17. Tei C, Nishimura RA, Seward JB, et al: Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10: 169-178.
18. Hall C: Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004; 6: 257-260.
19. Kim SH, Kim JS, Baek KK, et al: Role of NT- proBNP in evaluation of functional status in congestive heart failure. Korean Circ J 2004; 34: 894-899.
20. Choi JY: The role of brain natriuretic peptide in the patients with acute dyspnea in the emergency department. Korean Circ J 2007; 37: 464-469.
21. Luers C, Wachter R, Kleta S, et al: Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction. Clin Res Cardiol 2010; 99: 217-226.
22. Dao Q, Krishnaswamy P, Kazanegra R, et al: Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001; 37: 379-385.
23. Olsen MH, Hansen TW, Christensen MK, et al: N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 2005; 46: 660-666.
24. McCord J, Mundy BJ, Hudson MP, et al: Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 2004; 164: 2247-2252.
25. Horwich TB, Fonarow GC, Hamilton MA, et al: The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001; 38: 789-795.
26. Levine B, Kalman J, Mayer L, et al: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241.
27. Sarzani R, Dessi-Fulgheri P, Paci VM, et al: Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 1996; 19: 581-585.
28. Ommen SR, Nishimura RA, Appleton CP, et al: Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler- catheterization study. Circulation 2000; 102: 1788-1794.
29. Sengenes C: Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women. Int J Obes Relat Metab Disord 2002; 26: 24-32.
30. Kalra PR, Tigas S: Regulation of lipolysis: natriuretic peptides and the development of cachexia. Int J Cardiol 2002; 85: 125-132.
31. Bhalla MA, Chiang A, Epshteyn VA, et al: Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol 2004; 44: 1047-1052